1-6 of 6
Byung Park, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI) Predicts Survival and Tolerance of Ibrutinib Therapy in Patients with CLL: A Multicenter Retrospective Cohort Study

Max J. Gordon, MD, Andy Kaempf, MS, Andrea Sitlinger, MD, Tareq Salous, Hamood Alqahtani, MBBS, Michael C. Churnetski, Paul Wisniewski, BS, Xavier Issac Rivera, BS, Krish Patel, MD, Daniel O. Persky, MD, Jonathon B. Cohen, MDMS, Michael Y. Choi, MD, Brian T. Hill, MD, Mazyar Shadman, MDMPH, Deborah M. Stephens, DO, Danielle M. Brander, MD, Byung Park, PhD, Alexey Danilov, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-136808
Published: 2020
Journal Articles

An Innovative Telemedicine Platform to Provide Expert Access to Patients with Chronic Lymphocytic Leukemia (CLL)

DR. Brian Koffman, John M. Pagel, MD PhD DSc, Andy Kaempf, Byung Park, PhD, Liza Avruch, Christopher Lee, PhD MS, Babak Movassaghi, PhD MBA, John C. Byrd, MD, Alan Skarbnik, MD, Matthew S. Davids, MD, Alexey Danilov, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4716.
https://doi.org/10.1182/blood-2019-123579
Published: 2019
Journal Articles

The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Novel Comorbidity Score Derived from a Large Multicenter Retrospective Cohort Study of Patients Treated with Ibrutinib and/or Chemo-Immunotherapy (CIT)

Max J. Gordon, MD, Andy Kaempf, Andrea Sitlinger, MD, Tareq Salous, Hamood Alqahtani, MBBS, Michael C. Churnetski, Paul Wisniewski, Xavier Issac Rivera, BS, Krish Patel, MD, Daniel O. Persky, MD, Jonathon B. Cohen, MDMS, Michael Y. Choi, MD, Brian T. Hill, MD, Mazyar Shadman, MD, Deborah M. Stephens, DO, Danielle M. Brander, MD, Byung Park, PhD, Alexey Danilov, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4286.
https://doi.org/10.1182/blood-2019-124631
Published: 2019
Journal Articles

SYK Inhibitor Entospletinib in Combination with Obinutuzumab Demonstrates Efficacy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Adam S. Kittai, MD, Scott R Best, BS, Bria Thurlow, BSc, Basak Gokcora, Andrzej Stadnik, MPH, BS, Renee MacKinnon, Taylor Hashiguchi Rowland, BS, Daniel O. Persky, MD, Byung Park, PhD, Stephen E Spurgeon, MD, Alexey Danilov, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4295.
https://doi.org/10.1182/blood-2019-123586
Published: 2019
Journal Articles

Impact of Individual Comorbidities on Treatment Outcomes in Chronic Lymphocytic Leukemia

Max J. Gordon, MD, Michael C Churnetski, BS, Hamood Alqahtani, MBBS, Xavier Issac Rivera, BS, Adam Kittai, MD, Nur Bruss, BS, Sheila Hoff, BSN, Michael Y. Choi, MD, Jonathon B. Cohen, MD MS, Daniel Persky, MD, Byung Park, PhD, Alexey V Danilov, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4848.
https://doi.org/10.1182/blood-2018-99-113917
Published: 2018
Journal Articles

Comparative Functional Genomic Analysis of Myelodysplasia (MDS) in Fanconi Anemia (FA).

Grover C. Bagby, MD, Shannon McWeeney, PhD, Jane Yates, Byung Park, PhD, R. Keaney Rathbun, Daniela Pilonetto, PhD, Richard Harris, MD, John Wagner, MD, Christina Harrington, PhD, Motomi Mori, PhD, Ricardo Pasquini, MD, D. Wade Clapp, MD
Journal: Blood
Blood (2006) 108 (11): 2636.
https://doi.org/10.1182/blood.V108.11.2636.2636
Published: 2006